Pneumococcal Conjugate Vaccine--Equally Effective for Everyone?
- PMID: 26987461
- PMCID: PMC4802350
- DOI: 10.3238/arztebl.2016.0137
Pneumococcal Conjugate Vaccine--Equally Effective for Everyone?
Comment on
-
The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Dtsch Arztebl Int. 2016 Mar 4;113(9):139-46. doi: 10.3238/arztebl.2016.0139. Dtsch Arztebl Int. 2016. PMID: 26987462 Free PMC article.
Similar articles
-
Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.Acta Paediatr. 2001 May;90(5):473-6. Acta Paediatr. 2001. PMID: 11430703
-
Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.Expert Rev Vaccines. 2002 Jun;1(1):65-74. doi: 10.1586/14760584.1.1.65. Expert Rev Vaccines. 2002. PMID: 12908513 Review.
-
[Pediatrics. Conjugate anti-pneumoccoccal vaccine: what are the results four years after introduction?].Rev Med Suisse. 2005 Jan 12;1(2):142, 144, 146-7. Rev Med Suisse. 2005. PMID: 15773216 French.
-
Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population.Eur Respir J. 2016 Nov;48(5):1492-1496. doi: 10.1183/13993003.00890-2016. Epub 2016 Aug 18. Eur Respir J. 2016. PMID: 27540017 No abstract available.
-
Pneumococcal conjugate vaccine for young children.Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Manag Care. 2000. PMID: 11116663 Review.
Cited by
-
Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen.Virulence. 2017 Aug 18;8(6):875-890. doi: 10.1080/21505594.2016.1278334. Epub 2017 Jan 6. Virulence. 2017. PMID: 28059611 Free PMC article.
-
Mind the "Vaccine Fatigue".Front Immunol. 2022 Mar 10;13:839433. doi: 10.3389/fimmu.2022.839433. eCollection 2022. Front Immunol. 2022. PMID: 35359948 Free PMC article. Review.
References
-
- Singanayagam A, Chalmers JD, Welte T. Epidemiology of CAP in Europe. Eur Respir Monogr. 2014;63:1–12.
-
- AQUA-Instituts GmbH 2014. Göttingen. 2015. Qualitätsreport; pp. 26–30.
-
- Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-Year Mortality after Community-acquired Pneumonia. A prospective cohort. Am J Respir Crit Care Med. 2015;192:597–604. - PubMed
-
- Ewig S, Klapdor B, Pletz MW, et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 2012;67:132–138. - PubMed
-
- Welte T. New antibiotic development: the need versus the costs. Lancet Infect Dis. 2016 pii: S1473-3099(16)00068-2. [Epub ahead of print] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources